Indraprastha Apollo Hospital

Indraprastha Apollo Hospital is one of India's most iconic medical institutions, the flagship New Delhi hospital of Apollo Hospitals – India's largest private healthcare group – and the first hospital in India to receive Joint Commission International accreditation, which it has maintained across four consecutive accreditation cycles spanning over two decades. This unbroken JCI record is a powerful testament to Apollo Delhi's sustained commitment to international quality standards. Established in 1996 on Mathura Road in South-East Delhi, Apollo Delhi occupies a sprawling campus with over 1,000 beds, 52 medical specialties and 14 modular operating theatres. The hospital's infrastructure has been continuously upgraded, incorporating the Da Vinci robotic surgical system, PET-MR and PET-CT imaging, 3T MRI, 128-slice CT and CyberKnife radiosurgery system alongside advanced cath labs for interventional cardiology and neuroradiology. Apollo Delhi's clinical specialties span the most demanding areas of modern medicine. Its cardiac programme – encompassing interventional cardiology, cardiac surgery, electrophysiology and rehabilitation – is one of the highest-volume and most experienced in North India. The oncology programme integrates surgical, medical and radiation oncology with bone marrow transplant in a multidisciplinary framework managing thousands of new cancer cases annually. The transplant programme has performed thousands of kidney and liver transplants, making Apollo Delhi one of India's most experienced transplant centres. Its IVF programme has guided thousands of couples through successful fertility treatment. Apollo Delhi's International Patient Centre staffed with dedicated consultants and interpreters in 20+ languages provides personalised assistance with visa facilitation, airport pickup, accommodation, international insurance coordination and direct billing for patients covered by over 100 international insurance providers. Telemedicine capabilities allow international patients to begin clinical assessment before travelling, with remote specialist consultation enabling pre-arrival treatment planning that reduces the duration of in-person visits. Apollo Delhi draws substantial international volumes from SAARC, the Middle East, Africa and the CIS states. Its combination of JCI accreditation, 52 specialties, advanced technology and world-class clinical talent makes it one of the most complete and internationally trusted medical destinations in Delhi NCR. Apollo Delhi's commitment to quality extends beyond JCI accreditation into continuous clinical performance monitoring. The hospital operates a real-time clinical dashboard tracking infection rates, surgical mortality, length of stay and patient satisfaction scores — metrics that are benchmarked against JCI international standards and reported transparently to the hospital's clinical governance board. This culture of accountability and continuous improvement has been central to Apollo Delhi's ability to maintain the highest accreditation standards across four JCI cycles. The hospital's digital health platform — Apollo 24/7 — enables international patients to book video consultations, share medical records securely, track investigation results and communicate with their care team remotely before, during and after treatment visits. This telemedicine infrastructure is particularly valuable for international patients managing complex conditions that require ongoing specialist input between in-person visits to Delhi. Apollo Hospitals Group's scale — 70+ hospitals across India — provides Apollo Delhi patients with the additional security of knowing that if they require ongoing care upon returning to their home country's nearest Apollo facility, their medical records and treatment protocols transfer seamlessly within the group's unified digital health records system. For international patients from India's SAARC neighbours, the Gulf and Africa who travel repeatedly for serial oncology treatment or long-term monitoring, this network continuity is a significant advantage.